Catherine H. Marshall, MD, MPH
Catherine H. Marshall, MD, MPH, is an Assistant Professor of Oncology in the Department of Oncology, Division of Genitourinary Oncology at the Johns Hopkins University School of Medicine in Baltimore, Maryland. Her clinical practice and research are focused on prostate cancer.
Articles by Catherine H. Marshall, MD, MPH
Drs. Marshall, Reimers, and Dorff discuss toxicities from single-agent and combination-based HR inhibitors.
Drs. Marshall, Reimers, and Dorff discuss PARP inhibitor strategies for BRCA-mutated patients throughout the care continuum.
Drs. Marshall, Bryce, and Castro discuss incorporating mCRPC PARP inhibitor toxicity and outcomes data into practice.
Drs. Marshall, Bryce, and Castro discuss PARP inhibitor monotherapy vs in combination with AR-targeting agents for mCRPC.
Dr. Catherine H. Marshall is interviewed on the use and future of chemotherapy for the treatment of advanced prostate cancer.
Dr Catherine Handy Marshall gives prostate cancer patients care advice beyond appointments and medical interventions.
Highlights from ASCO 2022, including the role of doublet therapy (ADT combined with a novel oral antiandrogen drug).
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.